Cargando…
Does immunotoxicity of nanomaterials depend on the individual pre-existing conditions? A need for a personalised testing strategy
Autores principales: | Boraschi, D., Italiani, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461785/ http://dx.doi.org/10.1016/S0378-4274(21)00281-2 |
Ejemplares similares
-
Immunotoxicity of Carbon-Based Nanomaterials, Starring Phagocytes
por: Svadlakova, Tereza, et al.
Publicado: (2022) -
Editorial: Interaction of Nanomaterials with the Immune System: Role in Nanosafety and Nanomedicine
por: Boraschi, Diana, et al.
Publicado: (2017) -
In Vitro and In Vivo Models to Assess the Immune-Related Effects of Nanomaterials
por: Boraschi, Diana, et al.
Publicado: (2021) -
A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements
por: Giannakou, Christina, et al.
Publicado: (2016) -
A Step-by-Step Approach to Improve Clinical Translation of Liposome-Based Nanomaterials, a Focus on Innate Immune and Inflammatory Responses
por: Della Camera, Giacomo, et al.
Publicado: (2021)